
Alnylam Pharmaceuticals is seeking an imaginative physician drug developer. This is an opportunity to provide clinical leadership in developing RNAi therapeutics in Alnylam’s rapidly expanding portfolio, which spans the areas of rare genetic diseases, cardio-metabolic diseases, neuroscience, hematology and hepatology. The successful candidate’s primary role will be to drive the pipeline forward through leadership of clinical development programs. While the primary focus responsibility will be as
The Associate Director of Regulatory Affairs Strateg y will work on assigned programs with the respective Global Regulatory Portfolio Lead, Global Regulatory Lead and cross-functional team to lead the regulatory strategy and facilitate submission of data packages to the EMA. The role is expected to serve as an EU Regional Lead for our mid/late-stage CNS programs and may have the opportunity to be the Regulatory Program Lead for early programs in Alnylam pipeline. The role is responsible for plan
The Associate Director of Regulatory Affairs Strategy will work on assigned programs with the respective Global Regulatory Portfolio Lead, Global Regulatory Lead and cross-functional team to lead the regulatory strategy and facilitate submission of data packages to the EMA. The role is expected to serve as an EU Regional Lead for our mid/late-stage CNS programs and may have the opportunity to be the Regulatory Program Lead for early programs in Alnylam pipeline. The role is responsible for plann
In your role as Medical Affairs Manager, you will be required to develop a deep understanding of the relevant therapy area, as well as the clinical development and data supporting Alnylam medicines within the scope of the Medical Affairs Manager role. As a true subject matter expert the Medical Affairs Manager has a high degree of credibility both internally and externally. They are expected to develop a strategic KOL network and to use engagements with these individuals to systematically gather
Overview The Senior Manager, Medical Writing will partner closely with cross-functional project teams to plan, develop, and deliver high-quality clinical and regulatory documents in compliance with global regulations, Good Clinical Practice (GCP), and internal SOPs. This role plays a key part within the Central Nervous System (CNS) therapeutic area, contributing both hands-on expertise and strategic oversight while collaborating with internal stakeholders and external partners. This hybrid posit
The role requires development of a deep understanding of the relevant therapy area, as well as the clincal development and data supporting Alnylam medicines within the scope of the Medical Affairs Manager role. As a true subject matter expert the Medical Affairs Manager has a high degree of credibility both internally and externally. They are expected to develop a strategic KOL network and to use engagements with these individuals to systematically gather relevant insights for Alnylam and, where
The role requires development of a deep understanding of the relevant therapy area, as well as the clincal development and data supporting Alnylam medicines within the scope of the Medical Affairs Manager role. As a true subject matter expert the Medical Affairs Manager has a high degree of credibility both internally and externally. They are expected to develop a strategic KOL network and to use engagements with these individuals to systematically gather relevant insights for Alnylam and, where
Alnylam (Nasdaq: ALNY) is delivering on a bold vision to turn scientific possibility into reality, with a robust RNA interference (RNAi) therapeutics platform. As the pioneer in RNAi and the leading RNAi therapeutics company, we have always been uncompromisingly dedicated to translating the breakthrough science into transformational medicines to help as many people as possible. Long focused on rare and genetic diseases, our scientific advances are now allowing us to bring the power of RNAi thera
Alnylam (Nasdaq: ALNY) is delivering on a bold vision to turn scientific possibility into reality, with a robust RNA interference (RNAi) therapeutics platform. As the pioneer in RNAi and the leading RNAi therapeutics company, we have always been uncompromisingly dedicated to translating the breakthrough science into transformational medicines to help as many people as possible. Long focused on rare and genetic diseases, our scientific advances are now allowing us to bring the power of RNAi thera
Overview The Senior Clinical Data Manager will lead and contribute to data management activities in support of Alnylam studies across all stages of clinical drug development. This position reports to the Senior Manager, Data Management. Summary Of Key Responsibilities Contribute to data management activities as a lead study data manager in support of Alnylam clinical studies Lead database build activities including leading cross-functional review of eCRF content, review of edit check specificati
Overview The Associate Director, Clinical Pharmacology supports a rapidly expanding clinical portfolio of RNAi therapeutics within the CNS franchise. This role provides clinical pharmacology expertise across clinical-stage programs, with a strong focus on pharmacokinetics (PK), pharmacodynamics (PD), and PK/PD analyses to inform clinical development and regulatory decision-making. The position requires strong scientific expertise, critical thinking, and the ability to independently interpret and
Overview The Associate Director, Clinical Pharmacology supports a rapidly expanding clinical portfolio of RNAi therapeutics within the CNS franchise. This role provides clinical pharmacology expertise across clinical-stage programs, with a strong focus on pharmacokinetics (PK), pharmacodynamics (PD), and PK/PD analyses to inform clinical development and regulatory decision-making. The position requires strong scientific expertise, critical thinking, and the ability to independently interpret and